gastric cancer
DESCRIPTION
GASTRIC CANCER. GASTRIC CANCER. 4% 5 th position 2 nd cause of cancer related death in the world 5 y survival rate B:F=2:1 More frequent in Jap an, Latin America , Far East, North Europe. Incidence is droping. Pathology. Adenocarcinom a 90% Sarcom a Limfo ma. CAUSES. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: GASTRIC CANCER](https://reader035.vdocuments.us/reader035/viewer/2022062301/56813e4c550346895da83a8c/html5/thumbnails/1.jpg)
GASTRIC CANCERGASTRIC CANCER
![Page 2: GASTRIC CANCER](https://reader035.vdocuments.us/reader035/viewer/2022062301/56813e4c550346895da83a8c/html5/thumbnails/2.jpg)
GASTRIC CANCERGASTRIC CANCER 4%4% 5 5thth position position
22ndnd cause of cancer related cause of cancer related death in the worlddeath in the world
5 y survival rate5 y survival rate B:F=2:1B:F=2:1 More frequent in More frequent in JapJapan, Latin an, Latin AmericaAmerica, ,
Far East, North Europe. Far East, North Europe. Incidence is dropingIncidence is droping
![Page 3: GASTRIC CANCER](https://reader035.vdocuments.us/reader035/viewer/2022062301/56813e4c550346895da83a8c/html5/thumbnails/3.jpg)
PathologyPathology
AdenocarcinomAdenocarcinomaa 90% 90%SarcomSarcomaaLimfoLimfomama
![Page 4: GASTRIC CANCER](https://reader035.vdocuments.us/reader035/viewer/2022062301/56813e4c550346895da83a8c/html5/thumbnails/4.jpg)
CAUSESCAUSES 66-75% 66-75% can be prevented with diet using can be prevented with diet using
high quantity of fruits and vegetables and high quantity of fruits and vegetables and low in salty foods. low in salty foods.
Integral cereals and green teea can reduce Integral cereals and green teea can reduce the incidence the incidence
Vitamin C şi carotenoiVitamin C şi carotenoidsds probably decrease probably decrease the riskthe risk
AlcoAlcohhololmay increase the risk of GC in may increase the risk of GC in cardia region cardia region
Smoking increases the riskSmoking increases the risk
![Page 5: GASTRIC CANCER](https://reader035.vdocuments.us/reader035/viewer/2022062301/56813e4c550346895da83a8c/html5/thumbnails/5.jpg)
ETHIOLOGYETHIOLOGY Atriphic gastritis Atriphic gastritis 9% 9% will develop GCwill develop GC Chronic inflammationChronic inflammation – – destruction of glandsdestruction of glands – – lower capacity of lower capacity of
acid secretion – intestinal metaplasiaacid secretion – intestinal metaplasia CaCausesuses
Helicobacter pyloriHelicobacter pylori Ac anti parietalAc anti parietal cells cells – – Biermer Biermer Antral resection Antral resection
![Page 6: GASTRIC CANCER](https://reader035.vdocuments.us/reader035/viewer/2022062301/56813e4c550346895da83a8c/html5/thumbnails/6.jpg)
ETHIOLOGYETHIOLOGY Helicobacter pyloriHelicobacter pylori
Distal GC + association with atrophyDistal GC + association with atrophy Appears to be protective against procimal GC Appears to be protective against procimal GC 11// 97 97 infectet patients develop infectet patients develop CG CG Inf:noninf=8:1Inf:noninf=8:1, ONLY CERTAIN FENOTYPES, ONLY CERTAIN FENOTYPES
![Page 7: GASTRIC CANCER](https://reader035.vdocuments.us/reader035/viewer/2022062301/56813e4c550346895da83a8c/html5/thumbnails/7.jpg)
ETHIOLOGYETHIOLOGY PolPolyyppss
Hiperplastic – 80%Hiperplastic – 80% High risk overHigh risk over 0,5 0,5 ccmm
AdenomatoAdenomatoss Very high risckVery high risck
Familial riskFamilial risk 2-3X 2-3X higherhigher MutaMutation in genetion in gene
CHD1 CHD1 --E-cadherina E-cadherina role in diferencietion role in diferencietion and cel arhitectureand cel arhitecture
Molecular fenotypeMolecular fenotype c-met, K-sam ic-met, K-sam involved nvolved
in cell grothin cell groth p53 p53 suppressor genesuppressor gene– –
64%64% cyclin Ecyclin E
![Page 8: GASTRIC CANCER](https://reader035.vdocuments.us/reader035/viewer/2022062301/56813e4c550346895da83a8c/html5/thumbnails/8.jpg)
PATHOLOGYPATHOLOGY Intestinal Intestinal
AtrophyAtrophy – – metaplametaplasiasia - - displadisplasiasia – adenom – adenomaa - cancer- cancer
Difuz – linitDifuz – linitis is plasticaplastica Submucosal Submucosal
invasioninvasion
![Page 9: GASTRIC CANCER](https://reader035.vdocuments.us/reader035/viewer/2022062301/56813e4c550346895da83a8c/html5/thumbnails/9.jpg)
Macroscopic – Macroscopic – BorrmannBorrmann TTyyppe e I - polipoid I - polipoid well well
defined defined TTyyppee II – polip II – polipoid with oid with
marked infiltration marked infiltration TTyyppee III – III – ulceratio with ulceratio with
infiltrated margins infiltrated margins Tip IV – linitTip IV – linitis is plasti plasticaca
Microscopic – OMSMicroscopic – OMS AdenocarcinomAdenocarcinomaa – –
intestinal, difuintestinal, difusese AdenocarcinomAdenocarcinomaa papilar papilaryy AdenocarcinomAdenocarcinomaa tubular tubular Adenoacrcinom mucinos Adenoacrcinom mucinos
(>50% mucino(>50% mucinous cellsus cells)) Signet cells carcinomaSignet cells carcinoma
(>(>50% signet cells50% signet cells)) AAdenosdenosqquamosuamos carcinoma carcinoma Squamos cell carcinomaSquamos cell carcinoma Small cells carcinomaSmall cells carcinoma NondiferentiatedNondiferentiated altelealtele
![Page 10: GASTRIC CANCER](https://reader035.vdocuments.us/reader035/viewer/2022062301/56813e4c550346895da83a8c/html5/thumbnails/10.jpg)
![Page 11: GASTRIC CANCER](https://reader035.vdocuments.us/reader035/viewer/2022062301/56813e4c550346895da83a8c/html5/thumbnails/11.jpg)
![Page 12: GASTRIC CANCER](https://reader035.vdocuments.us/reader035/viewer/2022062301/56813e4c550346895da83a8c/html5/thumbnails/12.jpg)
Primary tumor (T): Tis = carcinoma in situ: intraepithelial tumor without invasion of lamina propria T1 = tumor invades lamina propria or submucosa T2 = tumor invades muscularis propria or subserosa T3* = tumor penetrates serosa (visceral peritoneum) without invasion of adjacent structures T4**,*** = tumor invades adjacent structures
*A tumor may penetrate the muscularis propria with extension into the gastrocolic or gastrohepatic ligaments or into the greater or lesser omentum without perforation of the visceral peritoneum. **Structures adjacent to the stomach include the spleen, transverse colon, liver, diaphragm, pancreas, abdominal wall, adrenal gland, kidney, small intestine, and retroperitoneum. ***Intramural extension to the duodenum or esophagus is classified by the depth of greatest invasion in any of these sites, including the stomach).
Regional lymph nodes (N): Include the perigastric nodes along the lesser and greater curvatures, and the nodes along the left gastric, common hepatic, splenic, and celiac arteries. N0 = no regional lymph node metastasis N1 = metastasis to 1–6 regional lymph nodes N2 = metastasis in 7–15 regional lymph nodes N3 = metastasis in more than 15 regional lymph nodes
Distant metastasis (M): M0 = no distant metastasis M1 = distant metastasis
![Page 13: GASTRIC CANCER](https://reader035.vdocuments.us/reader035/viewer/2022062301/56813e4c550346895da83a8c/html5/thumbnails/13.jpg)
GradingGrading G1 G1 -- well diferentiated well diferentiated->95% gland->95% glandss G2 – moderat diferenG2 – moderat diferentiatedtiated – 50-95% – 50-95%
glandglandss G3 – G3 – poor diferentiatedpoor diferentiated - <49% gland - <49% glandss
Adc tubular – G1Adc tubular – G1 Adc Adc signet cellssignet cells – G3 – G3 Adc Adc small celss and non diferetiated small celss and non diferetiated – G4 – G4
![Page 14: GASTRIC CANCER](https://reader035.vdocuments.us/reader035/viewer/2022062301/56813e4c550346895da83a8c/html5/thumbnails/14.jpg)
CLINICA CLINICA PRESENTATIONPRESENTATION SubjectivSubjectiv
General neoplastic simptomsGeneral neoplastic simptoms DispepsiaDispepsia UGI bleedingUGI bleeding
ObObjjectivectiv TumorTumor palpable palpable HepatomegalHepatomegaly, ascites, y, ascites,
jaundice, splenomagalyjaundice, splenomagaly Sister Mary Joseph –Sister Mary Joseph – sign sign
(umbilkical nodule) (umbilkical nodule) VirchowVirchow sign sign – – left left
supraclavicular LNsupraclavicular LN Krukenberg –ovarKrukenberg –ovarian MTSian MTS Blumer – Blumer – rectal palpable rectal palpable
mass mass Trousseau – Trousseau – migrating flebitis migrating flebitis Leser-Trelat – Leser-Trelat – sseboreborhheiceic
keratitiskeratitis LabLab
AnemiaAnemia OOcultcult bleeding bleeding ACE, CA 19.9 ACE, CA 19.9
![Page 15: GASTRIC CANCER](https://reader035.vdocuments.us/reader035/viewer/2022062301/56813e4c550346895da83a8c/html5/thumbnails/15.jpg)
Rx Rx barium barium
![Page 16: GASTRIC CANCER](https://reader035.vdocuments.us/reader035/viewer/2022062301/56813e4c550346895da83a8c/html5/thumbnails/16.jpg)
![Page 17: GASTRIC CANCER](https://reader035.vdocuments.us/reader035/viewer/2022062301/56813e4c550346895da83a8c/html5/thumbnails/17.jpg)
CT,CT, MRI MRI, echoendoscop, echoendoscopyy+biops+biopsyybrush brush citologcitologyy, laparoscop, laparoscopyy, , lapro echographylapro echography
![Page 18: GASTRIC CANCER](https://reader035.vdocuments.us/reader035/viewer/2022062301/56813e4c550346895da83a8c/html5/thumbnails/18.jpg)
COMPLICATIONSCOMPLICATIONSBleeding Bleeding PerforationPerforationObstructionObstructionPenetrationPenetration
![Page 19: GASTRIC CANCER](https://reader035.vdocuments.us/reader035/viewer/2022062301/56813e4c550346895da83a8c/html5/thumbnails/19.jpg)
TRTREEATMENTATMENT SURGICALSURGICAL RezecRezectiontion
R0 – R0 – complete, no complete, no microscopic tumor microscopic tumor leftleft
R1 – R1 – microscopic microscopic tumor left in situtumor left in situ
R2 – R2 – macrosocopic macrosocopic residual tumorresidual tumor
LimfadenectomLimfadenectomyy D1 – staD1 – stationstions 1-6 1-6 D2 – staD2 – stationstions 7-11 7-11 D3 – staD3 – stationstions 12-14 12-14 D4 – staD4 – stationstions 15-16 15-16
OmentectomOmentectomyy
![Page 20: GASTRIC CANCER](https://reader035.vdocuments.us/reader035/viewer/2022062301/56813e4c550346895da83a8c/html5/thumbnails/20.jpg)
Endoscopic Endoscopic treatmenttreatment
Mucosal resection in Mucosal resection in early gastric cancerearly gastric cancer
PaliativPaliativee SclerotSclerothheraperapyy Laser destructionLaser destruction StentStent
![Page 21: GASTRIC CANCER](https://reader035.vdocuments.us/reader035/viewer/2022062301/56813e4c550346895da83a8c/html5/thumbnails/21.jpg)
![Page 22: GASTRIC CANCER](https://reader035.vdocuments.us/reader035/viewer/2022062301/56813e4c550346895da83a8c/html5/thumbnails/22.jpg)
![Page 23: GASTRIC CANCER](https://reader035.vdocuments.us/reader035/viewer/2022062301/56813e4c550346895da83a8c/html5/thumbnails/23.jpg)
TRTREEATMENTATMENT ChCheemotmothheraperapyy
Neoadjuvant Neoadjuvant / / adjuvantadjuvant 5-FU, doxorubicin şi mitomycin C (FAM)5-FU, doxorubicin şi mitomycin C (FAM) ImmunochemoterapImmunochemoterapy – CHT bound to y – CHT bound to
specific tumoral ATB. Agspecific tumoral ATB. Ag RadioterapRadioterapyy
neoadjuvantneoadjuvant CChemoradiationhemoradiation
AdjuvantAdjuvant Major discussionsMajor discussions